RARX - Ra Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts99910
Avg. Estimate-0.5-0.53-2-2.4
Low Estimate-0.53-0.58-2.08-2.9
High Estimate-0.44-0.47-1.81-1.93
Year Ago EPS-0.51-0.47-2.06-2
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts8899
Avg. Estimate750k250k890k6.06M
Low EstimateN/AN/AN/AN/A
High Estimate3M2M3M44M
Year Ago SalesN/A2.5M2.5M890k
Sales Growth (year/est)N/A-90.00%-64.40%580.90%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.49-0.52-0.48-0.49
EPS Actual-0.51-0.47-0.45-0.52
Difference-0.020.050.03-0.03
Surprise %-4.10%9.60%6.20%-6.10%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.5-0.53-2-2.4
7 Days Ago-0.51-0.54-2-2.37
30 Days Ago-0.5-0.53-1.99-2.37
60 Days Ago-0.5-0.53-1.99-2.37
90 Days Ago-0.52-0.55-2.01-2.37
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days221N/A
Up Last 30 Days432N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1112
Growth EstimatesRARXIndustrySectorS&P 500
Current Qtr.2.00%N/AN/A-0.02
Next Qtr.-12.80%N/AN/A0.07
Current Year2.90%N/AN/A-0.02
Next Year-20.00%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A